Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Quince Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +2 vs. Q3 2024
- Shares held
- 5.11M
- −84.8K (−1.6%) vs. Q3 2024
- Total value
- $9.55M
- +$5.51M (+136.5%) vs. Q3 2024
- New holders
- 9
- 11 more added
- Sold out
- 7
- 5 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $4.74M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,272,340 | $2.38M | 0.00% | +72,692+6.1% | Added |
| EPIQ Capital Group, LLC | 824,782 | $1.54M | 0.40% | −1,160−0.1% | Reduced |
| Renaissance Technologies LLC | 523,050 | $978.1K | 0.00% | +474+0.1% | Added |
| BlackRock, Inc. | 447,733 | $837.3K | 0.00% | +89,375+24.9% | Added |
| Geode Capital Management, LLC | 375,932 | $703.2K | 0.00% | +36,807+10.9% | Added |
| HighTower Advisors, LLC | 341,570 | $638.7K | 0.00% | 00.0% | Unchanged |
| Shay Capital LLC | 276,799 | $517.6K | 0.13% | +104,616+60.8% | Added |
| Alphabet Inc. | 189,122 | $353.7K | 0.02% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 142,958 | $267.3K | 0.06% | 00.0% | Unchanged |
| State Street Corp | 124,911 | $233.6K | 0.00% | +68,300+120.6% | Added |
| Mariner, LLC | 122,461 | $229.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 92,317 | $172.6K | 0.00% | +3,822+4.3% | Added |
| Scharf Investments, LLC | 91,061 | $170.3K | 0.01% | +91,061 | New |
| Morgan Stanley | 76,701 | $143.4K | 0.00% | +68,179+800.0% | Added |
| Northern Trust Corp | 50,524 | $94.5K | 0.00% | +16,501+48.5% | Added |
| Two Sigma Investments, LP | 30,341 | $56.7K | 0.00% | +30,341 | New |
| Virtu Financial LLC | 29,204 | $55.0K | 0.00% | +29,204 | New |
| Anfield Capital Management, LLC | 26,656 | $49.8K | 0.02% | +26,656 | New |
| HRT Financial LP | 20,232 | $37.0K | 0.00% | +20,232 | New |
| Kestra Advisory Services, LLC | 15,359 | $28.7K | 0.00% | +15,359 | New |
| Nixon Peabody Trust Co | 11,126 | $20.8K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 10,475 | $19.6K | 0.00% | +10,475 | New |
| Citigroup Inc | 5,165 | $9.66K | 0.00% | −11,962−69.8% | Reduced |
| Bank of America Corp | 3,029 | $5.66K | 0.00% | −154,949−98.1% | Reduced |
| Tower Research Capital LLC (TRC) | 1,697 | $3.17K | 0.00% | −3,852−69.4% | Reduced |
| UBS Group AG | 1,114 | $2.08K | 0.00% | +634+132.1% | Added |
| Advisor Group Holdings, Inc. | 782 | $1.46K | 0.00% | +505+182.3% | Added |
| JPMorgan Chase & Co | 545 | $1.02K | 0.00% | −3−0.5% | Reduced |
| JDM Financial Group LLC | 340 | $636 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 295 | $552 | 0.00% | 00.0% | Unchanged |
| Hurley Capital, LLC | 121 | $236 | 0.00% | +121 | New |
| Barclays PLC | 100 | $187 | 0.00% | 00.0% | Unchanged |
| Financial Avengers, Inc. | 100 | $187 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 75 | $140 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 74 | $138 | 0.00% | +74 | New |
| Almitas Capital LLC | 0 | $0 | 0.00% | −382,882−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −107,007−100.0% | Sold out |
| Intellectus Partners, LLC | 0 | $0 | 0.00% | −53,527−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −32,553−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −21,570−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −431−100.0% | Sold out |
| Financial Perspectives, Inc | 0 | $0 | 0.00% | −310−100.0% | Sold out |